Korean Journal of Health Education and Promotion (보건교육건강증진학회지)

Korean Society for Health Education and Promotion (한국보건교육건강증진학회)
권호 표지

Metabolically Obese Normal Weight (MONW)

정상체중 대사비만

  • Kang, Hyun-Joo (Division of Physical Education, SoonChunHyang University)
  • 강현주 (순천향대학교 체육학부)
  • Received : 2009.05.01
  • Accepted : 2009.06.13
  • Published : 2009.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Metabolically obese but normal weight(MONW) syndrome is characterized, with potentially increased risks for development of the insulin resistance or metabolic syndrome despite their normal body mass index(BMI) < 25 kg/m2. Such characteristics could confer upon MONW individuals a type 2 diabetes mellitus and cardiovascular diseases(CVD) risk however, research on MONW is scarce. MONW individuals have metabolic disturbances typical of obese persons and are identified by having a high amount of visceral fat, a low BMI, a high fat mass, a low lean body mass, low insulin sensitivity, and high triglyceride concentrations. The purpose of this study is to review several markers as potential modulators in individuals displaying the "MONW". Body fat appears to be functionally comparable with a dynamic endocrine organ, producing and secreting various adipocy tokines, such as leptin, adiponectin, CRP, tumor necrosis factor(TNF-), interleukin(IL)-6, all of which play an important role in the onset of cardiovascular disease, and insulin resistance. Otherwise, physical activity and a lower inflammation state might be helped to reduce the number of persons at risk of diabetes, CVD complications, or premature mortality. We should provide a method to optimal treatments resolving the emerging public health problem to prevention of MONW by providing guideline for physical activity as an optimal treatment for the MONW Korean. Furthermore we expect to develop a new strategy to manage MONW Korean in this society in terms of reducing medical costs and enhancing public health care for uprising population with MONW.

Keywords

References

  1. 김대중. 마른비만의 치료. 대학비만학회 춘계학술대회 연수강좌 2004;499-503
  2. 보건복지부. 2007 건강투자 전략을 위한 건강정책관 핵심지표. 서울: 보건복지부, 2007
  3. Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res. 2005;96:939-949 https://doi.org/10.1161/01.RES.0000163635.62927.34
  4. Chung S. et al., 8. Korean and Caucasian overweight premenopausal women have different relationship of body mass index to percent body fat with age. J Appl Physiol. 2005;99(1):103-107 https://doi.org/10.1152/japplphysiol.01153.2004
  5. Conus F, Allison DB, Rabasa-Lhoret R, St-Onge M, St-Pierre DH, Tremblay-Lebeau A and Poehlman ET. Metabolic and behavioral characteristics of metabolically obese but norma-weight women. J Clin Endocrionol Metab. 2004;89:5013-5020 https://doi.org/10.1210/jc.2004-0265
  6. Conus F, Rabasa-Lhoret R, Peronnet F. Characteristics of metabolically obese normal weight(MONW) subjects. Appl Physiol Nutr Metab. 2007;32:4-12 https://doi.org/10.1139/H06-092
  7. Dvorak RV, DeNino WF, Ades PA, Poehlman ET. Phenotypic characteristics associated with insulin resistance in metabolically obese but normal-weight young women. Diabetes 1999;48:2210-2214 https://doi.org/10.2337/diabetes.48.11.2210
  8. Fu Y, Luo N, Klein RL, Garvey WT. Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation. J Lipid Res. 2005;46(7):1369-1379 https://doi.org/10.1194/jlr.M400373-JLR200
  9. Greenberg AS, Obin MS. Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr 2006;83:461S-465S
  10. Haffner SM. Abdominal adiposity and cardiometabolic risk: Do we have all the answers? Am J Med. 2007;120(Suppl1):S10-S16
  11. Hollenbeck C, Reaven GM. Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance. J Clin Endocrinol Metab. 1987;64(6):1169-1173 https://doi.org/10.1210/jcem-64-6-1169
  12. Homma Y. Predictors of atherosclerosis. J Atheroscler Thromb 2004;11:265-270 https://doi.org/10.5551/jat.11.265
  13. Karelis AD. et al., 7. The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab 2005;90(7):4145-4150 https://doi.org/10.1210/jc.2005-0482
  14. Katsuki A. et al., 10 Increased visceral fat and serum levels of triglyceride are associated with insulin resistance in Japanese metabolically obese, normal weight subjects with normal glucose tolerance. Diabetes Care 2003;26:2341-2344 https://doi.org/10.2337/diacare.26.8.2341
  15. Katsuki A. et al., 9. Plasma levels of adiponectin are associated with insulin resistance and serum levels of triglyceride in Japanese metabolically obese, normal-weight men with normal glucose tolerance. Diabetes Care 2003;26:2964-2965 https://doi.org/10.2337/diacare.26.10.2964
  16. Katsuki A. et al., 7. Increased oxidative stress is associated with serum levels of triglyceride, insulin resistance, and hyperinsulinemia in Japanese metabolically obese, normal weight men. Diabetes Care 2004;27:631-632 https://doi.org/10.2337/diacare.27.2.631
  17. Katsuki A et al., 8. Quantitative insulin sensitivity check index is a useful indicator of insulin resistance in Japanese metabolically obese, normal-weight subjects with normal glucose tolerance. Endocr J 2005;52:253-257 https://doi.org/10.1507/endocrj.52.253
  18. Lemieux I. et al., 5. Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. Arterioscler Thromb Vasc Biol 2001;21:961-967 https://doi.org/10.1161/01.ATV.21.6.961
  19. Meigs JB. et al., 6. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab. 2006;91:2906-2912 https://doi.org/10.1210/jc.2006-0594
  20. Mohamed-Ali V, Pinkney JH, Coppack SW. Adipose tissue as an endocrine and paracrine organ. Int J Obes Relat Metab Disord 1998;22(12):1145-1158 https://doi.org/10.1038/sj.ijo.0800770
  21. Molero-Conejo E et al., 7. Lean adolescents with increased risk for metabolic syndrome. Arch Latinoam Nutr 2003;53:39-43
  22. Pedersen. et al., 5. Exercise and cytokines with particular focus on muscle-derived IL-6. Exerc Immunol Rev 2001;7:18-31
  23. Puglish MJ, Fernandez ML. Modulation of C-reactive protein, tumor necrosis factor-a, and adiponectin by diet, exercise, and weight loss. J Nutrition 2008;138:2293-2296 https://doi.org/10.3945/jn.108.097188
  24. Ridker PM. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001;103:1813-1818 https://doi.org/10.1161/01.CIR.103.13.1813
  25. Rokling-Andersen MH. et al., 7. Effects of long-term exercise and diet intervention on plasma adipokine concentations. Am J Clin Nutr 2007;86:1293-1301
  26. Rosenson RS, Brown AS. Statin use in acute coronary syndromes: cellular mechanisms and clinical evidence. Curr Opin Lipidol 2002;13:625-630 https://doi.org/10.1097/00041433-200212000-00005
  27. Ruderman NB, Schneider SH, Berchtold P. The "metabolicallyobese", normal-weight induvidual. Am J Clin Nutr 1981;34:1617-1621
  28. Ruderman N, Chrisholm D, Pi-Sunyer X, Schneider SH. The metabolically obese, normal-weight individual revisited. Diabetes 1998;47:6699-6713
  29. Shinozaki K, Kashiwagi A, Masada M, Okamura T. Molecular mechanisms of impaired endothelial function associated with insulin resistance. Curr Drug Targets Cardiovasc Haematol Disord 2004;4:1-11
  30. Sowers JR. Obesity as a cardiovascular risk factor. Am J Med 2003;115(Suppl8A):37S-41S
  31. Sowers JR. Endocrine functions of adipose tissue: focus on adiponectin. Clin Cornerstone 2008;9(1):32-40 https://doi.org/10.1016/S1098-3597(08)60026-5
  32. St-Onge MP, Janssen I, Heymsfield SB. Metabolic syndrome in normal-weight Americans. New definition of the of the metabolly obese, normal-weight individual. Diabetes Care 2004;27:2222-2228 https://doi.org/10.2337/diacare.27.9.2222